Oragenics Doses First Patient In Phase IIa Clinical Trial of ONP-002
Benzinga Newsdesk 6 months ago
NewsFDA
Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong enrollment velocity and significant unmet medical need
Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong enrollment velocity and significant unmet medical need